Beating earnings estimates typically leads to positive investor sentiment and can result in a short-term increase in stock price. Omega Therapeutics' better-than-expected loss indicates operational efficiency or cost management that was above analyst expectations, which could positively influence investor confidence and the stock's short-term trajectory.